Richard Sullivan: The State of Global Cancer Surgery from Political and Equity Perspectives
Richard Sullivan, Professor of Cancer and Global Health at King’s College London, shared his recent articles on LinkedIn:
“By any metric surgery fares badly on the global health agenda. A decade after the Lancet Global Surgery 2030 there has been glacial progress. Work examining the state of global cancer surgery from political and equity perspectives concurs that the international community still has little ‘feel’ for the capacity and research agenda needed to build high-quality services.
Major research funding organizations and international organizations continue their relentless and myopic focus on cancer drugs. Post-pandemic we have also looked at the state of global surgical systems resilience.
Despite some efforts to improve preparedness in the wake of the COVID-19 pandemic, measurement of healthcare investment and surgical preparedness metrics suggests that policymakers are not yet prioritizing surgical care.
Again this is being driven by a myopic focus on bio-surveillance and vaccine capacity with little regard for wider health systems lessons.”
Building resilient surgical systems that can withstand external shocks.
Authors: James C Glasbey, et al.
Inequities in global cancer surgery: Challenges and solutions.
Authors: Priya Ranganathan, et al.
Richard Sullivan is a Professor of Cancer and Global Health at King’s College London, where he directs the King’s Institute of Cancer Policy and co-directs the Conflict and Health Research Group. His research spans from global cancer studies to conflict and health, with a focus on capacity building in conflict zones, humanitarian medicine, women’s health, and digital innovation in surgery.
For more Updates, Follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023